Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma

Cell Death and Disease

Volumn 4, Issue 5, 2013, Pages

  Vara, D ^a   Morell, C ^a   Rodriguez Henche N ^a   Diaz Laviada, I ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Cannabinoids; HepG2; JWH 015; PPAR ; THC; TRIB3

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; DRONABINOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P62; REGULATOR PROTEIN; SMALL INTERFERING RNA; TRIBBLES HOMOLOG 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL LEVEL; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANILIDES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CANNABINOIDS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; HEP G2 CELLS; HUMANS; INDOLES; LIVER NEOPLASMS; PPAR GAMMA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

MUS;

EID: 84879362589     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.141     Document Type: Article

References (39)

1. Alves R. C, Alves D, Guz B, Matos C, Viana M, Harriz M et al. Advanced hepatocellular carcinoma. Review of targeted molecular drugs. Ann Hepatol 2011; 10: 21-27.
2. Waly Raphael S, Yangde Z, Yuxiang C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol 2012; 2012: 421673.
3. Fowler CJ, Gustafsson SB, Chung SC, Persson E, Jacobsson SO, Bergh A. Targeting the endocannabinoid system for the treatment of cancer-a practical view. Curr Top Med Chem 2010; 10: 814-827.
4. Guindon J, Hohmann AG. The endocannabinoid system and cancer: therapeutic implication. Br J Pharmacol 2011; 163: 1447-1463.
5. Velasco G, Sanchez C, Guzman M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 2012; 12: 436-444.
6. O'Sullivan SE. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 2007; 152: 576-582.
7. 2. Pharmacol Rev 2010; 62: 588-631.
8. Youssef J, Badr M. Peroxisome proliferator-activated receptors and cancer challenges and opportunities. Br J Pharmacol 2011; 164: 68-82.
9. Yessoufou A, Wahli W. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly 2010; 140: w13071.
10. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS et al. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci USA. 1995; 92: 7921-7925.
11. Maggiora M, Oraldi M, Muzio G, Canuto RA. Involvement of PPARalpha and PPARgamma in apoptosis and proliferation of human hepatocarcinoma HepG2 cells. Cell Biochem Funct 2010; 28: 571-577.
12. Tan XW, Xia H, Xu JH, Cao JG. Induction of apoptosis in human liver carcinoma HepG2 cell line by 5-allyl-7-gen-difluoromethylenechrysin. World J Gastroenterol 2009; 15: 2234-2239.
13. Zhou YM, Wen YH, Kang XY, Qian HH, Yang JM, Yin ZF. Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells. World J Gastroenterol 2008; 14: 2168-2173.
14. Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT et al. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. Br J Cancer 2012; 106: 1486-1494.
15. Galli A, Ceni E, Mello T, Polvani S, Tarocchi M, Buccoliero F et al. Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. Hepatology 2010; 52: 493-505.
16. Yu J, Shen B, Chu ES, Teoh N, Cheung KF, Wu CW et al. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro. Hepatology 2010; 51: 2008-2019.
17. Schmidt MV, Brune B, von Knethen A. The nuclear hormone receptor PPARgamma as a therapeutic target in major diseases. Sci World J 2010; 10: 2181-2197.
18. Giuliano M, Pellerito O, Portanova P, Calvaruso G, Santulli A, De Blasio A et al. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. Biochimie 2009; 91: 457-465.
19. Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G, Diaz-Laviada I. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ 2011; 18: 1099-1111.
20. O'Sullivan SE, Kendall DA. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 2010; 215: 611-616.
21. Burns KA, Vanden Heuvel JP. Modulation of PPAR activity via phosphorylation. Biochim Biophys Acta 2007; 1771: 952-960.
22. Takahashi Y, Ohoka N, Hayashi H, Sato R. TRB3 suppresses adipocyte differentiation by negatively regulating PPARgamma transcriptional activity. J Lipid Res 2008; 49: 880-892.
23. Zhou J, Zhang W, Liang B, Casimiro MC, Whitaker-Menezes D, Wang M et al. PPARgamma Activation Induces Autophagy in Breast Cancer Cells. Int J Biochem Cell Biol 2009; 41: 2334-2342.
24. Jiang M, Fernandez S, Jerome WG, He Y, Yu X, Cai H et al. Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy. Cell Death Differ 2010; 17: 469-481.
25. Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, Egia A et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 2009; 119: 1359-1372.
26. Mahmood DF, Jguirim-Souissi I, Khadija el H, Blondeau N, Diderot V, Amrani S et al. Peroxisome proliferator-activated receptor gamma induces apoptosis and inhibits autophagy of human monocyte-derived macrophages via induction of cathepsin L: potential role in atherosclerosis. J Biol Chem 2011; 286: 28858-28866.
27. Nakken B, Varga T, Szatmari I, Szeles L, Gyongyosi A, Illarionov PA et al. Peroxisome proliferator-activated receptor gamma-regulated cathepsin D is required for lipid antigen presentation by dendritic cells. J Immunol 2011; 187: 240-247.
28. Turk B, Bieth JG, Bjork I, Dolenc I, Turk D, Cimerman N et al. Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins. Biol Chem Hoppe Seyler 1995; 376: 225-230.
29. Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W et al. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology 2006; 43: 134-143.
30. Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines. Cancer 2002; 95: 2243-2251.
31. Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E et al. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Hepatology 2001; 33: 1087-1097.
32. Rumi MA, Sato H, Ishihara S, Kawashima K, Hamamoto S, Kazumori H et al. Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma. Br J Cancer 2001; 84: 1640-1647.
33. Toyoda M, Takagi H, Horiguchi N, Kakizaki S, Sato K, Takayama H et al. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells. Gut 2002; 50: 563-567.
34. Sozio MS, Lu C, Zeng Y, Liangpunsakul S, Crabb DW. Activated AMPK Inhibits PPAR{alpha} and PPAR{gamma} Transcriptional Activity in Hepatoma Cells. Am J Physiol Gastrointest Liver Physiol 2011; 301: G739-G747.
35. Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Egia A, Lorente M et al. TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action. Autophagy 2009; 5: 1048-1049.
36. Salazar M, Hernandez-Tiedra S, Torres S, Lorente M, Guzman M, Velasco G. Detecting autophagy in response to ER stress signals in cancer. Methods Enzymol 2011; 489: 297-317.
37. Wang J, Lv XW, Shi JP, Hu XS. Mechanisms involved in ceramide-induced cell cycle arrest in human hepatocarcinoma cells. World J Gastroenterol 2007; 13: 1129-1134.
38. Sanchez AM, Martinez-Botas J, Malagarie-Cazenave S, Olea N, Vara D, Lasuncion MA et al. Induction of the endoplasmic reticulum stress protein GADD153/CHOP by capsaicin in prostate PC-3 cells: a microarray study. Biochem Biophys Res Commun 2008; 372: 785-791.
39. Malagarie-Cazenave S, Olea-Herrero N, Vara D, Diaz-Laviada I. Capsaicin, a component of red peppers, induces expression of androgen receptor via PI3K and MAPK pathways in prostate LNCaP cells. FEBS Lett 2009; 583: 141-147.